Annette Tumolo
CIK 1717996 · View on SEC EDGAR ↗
Insider
First SEC filing: Sept. 27, 2017 · Latest: Sept. 27, 2017
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 32 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
32 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 12, 2021 | BIO | S | 4,800 | $750.05 | $3,600,240 | 4,593 Direct | -51.10% | Disposed | -50.2% (price as of 2026-08-21) |
| Nov. 11, 2021 | BIO | S | 500 | $750.00 | $375,000 | 4,593 Direct | -9.82% | Disposed | -50.2% (price as of 2026-08-21) |
| Nov. 11, 2021 | BIO | S | 613 | $748.84 | $459,039 | 5,093 Direct | -10.74% | Disposed | -50.1% (price as of 2026-08-21) |
| Nov. 11, 2021 | BIO | S | 433 | $748.08 | $323,919 | 5,706 Direct | -7.05% | Disposed | -50.0% (price as of 2026-08-21) |
| Aug. 26, 2021 | BIO | S | 600 | $792.58 | $475,548 | 3,099 Direct | -16.22% | Disposed | -52.8% (price as of 2026-08-21) |
| Nov. 6, 2020 | BIO | S | 246 | $641.53 | $157,816 | 4,122 Direct | -5.63% | Disposed | -41.7% (price as of 2026-08-21) |
| Nov. 6, 2020 | BIO | S | 734 | $640.78 | $470,333 | 4,368 Direct | -14.39% | Disposed | -41.7% (price as of 2026-08-21) |
| Nov. 6, 2020 | BIO | S | 220 | $639.62 | $140,716 | 5,102 Direct | -4.13% | Disposed | -41.6% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 12, 2021 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (600) | $159.32 | Sept. 7, 2026 | 600 | Disposed |
| Nov. 12, 2021 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (2,400) | $215.98 | Sept. 5, 2027 | 2,400 | Disposed |
| Nov. 12, 2021 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (1,800) | $326.15 | Sept. 4, 2028 | 1,800 | Disposed |
| Nov. 11, 2021 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (1,113) | $333.34 | Sept. 3, 2029 | 1,113 | Disposed |
| Nov. 11, 2021 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (433) | $524.30 | Sept. 2, 2030 | 433 | Disposed |
| Sept. 7, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (600) | — | — | 600 | Disposed |
| Sept. 5, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (600) | — | — | 600 | Disposed |
| Sept. 4, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (600) | — | — | 600 | Disposed |
| Sept. 3, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (557) | — | — | 557 | Disposed |
| Sept. 2, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (433) | — | — | 433 | Disposed |
| Nov. 6, 2020 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (1,200) | $159.32 | Sept. 7, 2026 | 1,200 | Disposed |
| Sept. 3, 2020 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (556) | — | — | 556 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 8 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 27, 2017 | BIO | Bio-Rad A Common Stock | 871 | Direct |
| Sept. 27, 2017 | BIO | Restricted Stock Units→ Bio-Rad A Common Stock (400) | 400 | Direct |
| Sept. 27, 2017 | BIO | Restricted Stock Units→ Bio-Rad A Common Stock (800) | 800 | Direct |
| Sept. 27, 2017 | BIO | Restricted Stock Units→ Bio-Rad A Common Stock (1,800) | 1,800 | Direct |
| Sept. 27, 2017 | BIO | Restricted Stock Units→ Bio-Rad A Common Stock (2,400) | 2,400 | Direct |
| Sept. 27, 2017 | BIO | Restricted Stock Units→ Bio-Rad A Common Stock (3,000) | 3,000 | Direct |
| Sept. 27, 2017 | BIO | Non-Qualified Stock Option (right to buy)→ Bio-Rad A Common Stock (3,000) | 3,000 | Direct |
| Sept. 27, 2017 | BIO | Non-Qualified Stock Option (right to buy)→ Bio-Rad A Common Stock (3,000) | 3,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $480,304 | — | $928,019 | $235,208 | $270,062 | — | $19,544 | $1,933,136 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.